In vitro cytotoxic effect of bread wheat gliadin on the LoVo human adenocarcinoma cell line

被引:27
作者
Dolfini, E
Elli, L
Dasdia, T
Bufardeci, B
Colleoni, M
Costa, B
Floriani, I
Falini, ML
Guerrieri, N
Forlani, F
Bardella, MT
机构
[1] Univ Milan, Dept Biol & Genet, I-20100 Milan, Italy
[2] Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy
[3] Univ Milan, IRCCS Osped Maggiore, Chair Gastroenterol, Milan, Italy
[4] Univ Milan, Dept Pharmacol Chemotherapy & Toxicol, Milan, Italy
[5] Univ Milano Bicocca, Dept Biosci & Biotechnol, Milan, Italy
[6] Univ Milan, Dept Agrifood Mol Sci, Milan, Italy
[7] Univ Milan, Coeliac Dis Ctr, Milan, Italy
关键词
gliadin; LoVo cell line; cytotoxicity;
D O I
10.1016/S0887-2333(02)00017-6
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The pathogenesis of celiac disease is not completely understood but, although the initial step of the process is still unclear, an altered immune response seems to play a major role. Previous studies of the biological properties of gliadin have highlighted its cytotoxic effects, and the aim of this study was to develop an in vitro technique to study them. The LoVo (human colon adenocarcinoma) cell line grown in two-dimensional cultures was exposed to different concentrations of digested bread wheat gliadin (62, 125, 250, 500 and 750 mug/ml) for 48 h, after which cell growth and oxidative balance (the content of reduced glutathione (GSH), and peroxidase, transferase and reductase activity) was evaluated. Other food proteins were used as controls. Our data revealed a statistically significant inhibition of cell growth in proportion to the gliadin concentration (from 26 to 100%), combined with a decrease in GSH content (-38% at 500 mug/ml) and reduced enzymatic activity (-30% at 500 mug/ml). The controls did not show any noxious effect. Our results confirm the usefulness of LoVo cells in evaluating gliadin cytotoxicity and that they can be used to investigate the biological properties of gliadin. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:331 / 337
页数:7
相关论文
共 40 条
[1]   In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope [J].
Anderson, RP ;
Degano, P ;
Godkin, AJ ;
Jewell, DP ;
Hill, AVS .
NATURE MEDICINE, 2000, 6 (03) :337-342
[2]   PREVENTION BY MANNAN AND OTHER SUGARS OF INVITRO DAMAGE OF RAT FETAL SMALL-INTESTINE INDUCED BY CEREAL PROLAMIN PEPTIDES TOXIC FOR HUMAN CELIAC INTESTINE [J].
AURICCHIO, S ;
DERITIS, G ;
DEVINCENZI, M ;
LATTE, F ;
MAIURI, L ;
PINO, A ;
RAIA, V ;
SILANO, V .
PEDIATRIC RESEARCH, 1987, 22 (06) :703-707
[3]   SUPEROXIDE AND HYDROGEN-PEROXIDE IN RELATION TO MAMMALIAN-CELL PROLIFERATION [J].
BURDON, RH .
FREE RADICAL BIOLOGY AND MEDICINE, 1995, 18 (04) :775-794
[4]   AGA technical review on celiac sprue [J].
Ciclitira, PJ .
GASTROENTEROLOGY, 2001, 120 (06) :1526-1540
[5]  
COLMAN RF, 1981, METHOD ENZYMOL, V17, P500
[6]  
DESSI M, 1992, ITAL J GASTROENTEROL, V24, P397
[7]   Characterization of a clonal human colon adenocarcinoma line intrinsically resistant to doxorubicin [J].
Dolfini, E ;
Dasdia, T ;
Arancia, G ;
Molinari, A ;
Calcabrini, A ;
Scheper, RJ ;
Flens, MJ ;
Gariboldi, MB ;
Monti, E .
BRITISH JOURNAL OF CANCER, 1997, 76 (01) :67-76
[8]  
DREWINKO B, 1979, CANCER RES, V39, P2630
[9]   FURTHER BIOLOGIC CHARACTERISTICS OF A HUMAN CARCINOEMBRYONIC ANTIGEN-PRODUCING COLON CARCINOMA CELL LINE [J].
DREWINKO, B ;
YANG, LY ;
BARLOGIE, B ;
ROMSDAHL, M ;
MEISTRICH, M ;
MALAHY, MA ;
GIOVANELLA, B .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1978, 61 (01) :75-83